
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ErbB4/HER4 CRISPR/Cas9 KO Plasmid (m) | sc-420220 | 20 µg | $397.00 |
Erbb4 encodes the receptor tyrosine kinase ErbB4/HER4, a member of the EGFR/ErbB family that binds neuregulins and other EGF-like ligands to regulate cell–cell signaling. Upon ligand-induced dimerization, ErbB4 activates downstream cascades including PI3K–AKT, RAS–RAF–MEK–ERK, JAK–STAT, and PLCγ/PKC, shaping programs of proliferation, survival, differentiation, and migration. In mouse tissues, ErbB4 is particularly important in neurodevelopment and synaptic signaling, as well as in epithelial and cardiac biology where it contributes to growth factor–driven patterning and homeostasis. Dysregulated ErbB4 signaling and altered pathway crosstalk have been implicated in cancer-related signaling networks and in neurological phenotypes, supporting its use as a mechanistic node for pathway and genotype–phenotype studies.
ErbB4/HER4 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Erbb4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Erbb4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Erbb4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ErbB4/HER4 protein expression.
This CRISPR knockout system enables efficient generation of Erbb4-deficient cell models for investigation of ErbB4/HER4 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.